LENZ
LENZ Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.30
+0.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.47x
- Price / sales
- 4.83x
- Price / cash flow
- -0.91x
Enterprise value
- Enterprise value
- -$116.2M
- EV / sales
- -5.41x
- EV / EBITDA
- 0.93x
- EV / EBIT
- 0.86x
- Market cap
- $103.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026